These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. What is the optimum perioperative drug therapy following lower-extremity vein bypass surgery? Henke P Semin Vasc Surg; 2009 Dec; 22(4):245-51. PubMed ID: 20006805 [TBL] [Abstract][Full Text] [Related]
11. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials. WAVE Investigators Am Heart J; 2006 Jan; 151(1):1-9. PubMed ID: 16368284 [TBL] [Abstract][Full Text] [Related]
12. Human umbilical vein versus heparin-bonded polyester for femoro-popliteal bypass: 5-year results of a prospective randomized multicentre trial. Scharn DM; Dirven M; Barendregt WB; Boll AP; Roelofs D; van der Vliet JA Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):61-7. PubMed ID: 17936036 [TBL] [Abstract][Full Text] [Related]
13. Antithrombotic therapy after infrainguinal bypass. Maufus M; Pernod G J Vasc Surg; 2014 Nov; 60(5):1367-1375. PubMed ID: 25441694 [TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of randomized trials comparing off-pump with on-pump coronary artery bypass graft patency. Parolari A; Alamanni F; Polvani G; Agrifoglio M; Chen YB; Kassem S; Veglia F; Tremoli E; Biglioli P Ann Thorac Surg; 2005 Dec; 80(6):2121-5. PubMed ID: 16305856 [TBL] [Abstract][Full Text] [Related]
15. The CARI guidelines. Pharmacological approaches to preventing vascular access failure. Polkinghorne K; Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S12-6. PubMed ID: 18713119 [No Abstract] [Full Text] [Related]
16. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery. Geraghty AJ; Welch K Cochrane Database Syst Rev; 2011 Jun; 2011(6):CD000536. PubMed ID: 21678330 [TBL] [Abstract][Full Text] [Related]
17. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent. Zimmermann N; Gams E; Hohlfeld T Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350 [TBL] [Abstract][Full Text] [Related]
18. Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials. Wijeysundera HC; Vijayaraghavan R; Nallamothu BK; Foody JM; Krumholz HM; Phillips CO; Kashani A; You JJ; Tu JV; Ko DT J Am Coll Cardiol; 2007 Jan; 49(4):422-30. PubMed ID: 17258087 [TBL] [Abstract][Full Text] [Related]
19. A critical analysis on the impact of antiplatelet therapy in the patency of infrainguinal bypass grafts. Sfyroeras GS; Saleptsis V; Argyriou C; Antoniou GA; Moll FL; Giannoukas AD Curr Vasc Pharmacol; 2013 Jan; 11(1):47-50. PubMed ID: 23391422 [TBL] [Abstract][Full Text] [Related]
20. Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration. BMJ; 1994 Jan; 308(6922):159-68. PubMed ID: 8312766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]